Find a TenderAwarded without competitionContract details notice

Published 24 Sept 2025, 10:28 BST

Official UK procurement notice

Ravulizumab IV Infusion · UK public procurement notice

Official notice

Authority: Belfast Health & Social Care Trust (Central government)

Direct award

Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)

Awarded value£1,200,000published award · exc. VAT

Awarded 24 Sept 2025no call for competition

Awarded to Alexion Pharmaceuticals

What is being bought

Published requirement description

Procurement of Ravulizumab IV Infusion.

The lotProcurement structure

single lot · no lot value published

Lot #1Awarded

Delivery: Northern Ireland

33600000 Pharmaceutical products

Procedure terms & legal framework

From the official record

Procedure method: Direct award
Legal basis: UKPGA · 2023/54 Procurement Act 2023
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Unspecified in notice
Recurring procurement: Unspecified in notice
First published: 24 Sept 2025, 10:28 BST
Last source update: 13 Oct 2025, 11:00 BST
Authority reference: DACPM2025-41
FTS notice number: 2025/S 000-064637
Latest notice: Contract details notice (UK7)
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-05a0b7 Find a Tender

Why no open competition: Single Suppliers Intellectual Property Exclusive Rights
Published justification: These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

How it was run

Official notice

Submission deadline: —

Timeline

3 Oct 2025 → 13 Oct 2025 · 2 dates

Standstill ends381 days ago
3 Oct 2025, 23:59 BST
Notice published372 days ago
13 Oct 2025, 11:00 BST

Notice history

4 events · 3 releases on Find a Tender · since 24 Sept 2025

Transparency notice published
24 Sept 2025, 10:28 BST
UK5
Contract award notice published
24 Sept 2025, 10:34 BST
UK6
Contract signature expected
4 Oct 2025, 23:59 BST
scheduled
Contract details notice published
13 Oct 2025, 11:00 BST
UK7

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast

Awards 1

Awarded value £1,200,0001 award exc. VAT

Contracts signed 1latest 9 Oct 2025

Awarded to	Value	Date	Status
Alexion Pharmaceuticals4 Oct 2025 – 30 Sept 2027	£1,200,000	24 Sept 2025	Awarded

Contracts

Ravulizumab IV Infusion · Alexion Pharmaceuticals
Signed
9 Oct 2025
Value
£1,200,000
Period
9 Oct 2025 – 30 Sept 2027
Status
active
No agreed KPIs: The contract value is below the relevant threshold for key performance indicators.

Contracting authority & participating public bodies

Belfast Health & Social Care Trust

Contracting authorityPublic authority - central governmentNorthern Irish devolved regulations apply GB-PPON: PLQJ-5727-JCLR Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital, Belfast, Northern Ireland, BT12 6BAContact email

Bidders & participating suppliers

1 commercial party on the notice

ALEXION PHARMA UK LIMITEDAwarded supplierGB-COH: 05970106GB-PPON: PQTX-1761-VLYY 1 Francis Crick Avenue, Cambridge, East of England, CB2 0AAContact email

Official documents & specifications (3)

Official links; attachments are not copied

Notices published for this procedure

Contract details notice contractContract details noticeUK7Contract details notice on Find a Tender13 Oct 2025, 11:00 BST
Contract award notice awardContract award noticeUK6Contract award notice on Find a Tender24 Sept 2025, 10:34 BST
Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender24 Sept 2025, 10:28 BST